Innovative Drug Discovery Platform_KMD Bioscience

>>

Antibody Platform

>>

Innovative Drug Discovery Platform

KMD Bioscience will continue to deepen its commitment to the field of innovative drug discovery, driving service upgrades through technological iteration. We will accelerate the integration of AI‑assisted drug design, automated high‑throughput screening, and next‑generation antibody engineering platforms to build an efficient translational pipeline from target discovery to preclinical candidate compounds (PCCs). Concurrently, we plan to expand our deep‑development capabilities for novel biologics, including bispecific antibodies, antibody–drug conjugates (ADCs), and nanobodies, while further enhancing the precision of structure‑based drug design (SBDD) and computational modeling, thereby accelerating the translation of breakthrough therapies from molecular discovery to clinical validation.

General Process

Innovative Drug Discovery PlatformGeneral Process

Customer Inquiry
Plan Confirmation
Contract Signing
Project Launch
Product Delivery

Innovative Drug Discovery Platform

Innovative Drug Discovery Platform

Customer Reviews

The collaboration with KMD Bioscience has been very pleasant. Any issues encountered during the experiments were promptly addressed. Although the project timeline was longer than anticipated, we ultimately obtained sequences with the desired high affinity—truly satisfying.

Mr. L**
KMD Bioscience places special emphasis on personalized customization, offering multiple optimization solutions tailored to the unique needs of our project. Each step is strictly executed in accordance with our requirements.

Davis**
KMD Bioscience tailored a drug development plan specifically for our project, particularly excelling in drug screening and optimization to precisely meet our specific needs.

Dr. J**
In the innovative drug development services conducted by KMD Bioscience, all experiments—whether in target validation, drug screening, or efficacy evaluation—were executed to high standards, with results exceeding our expectations.

Mr. L**
KMD Bioscience thoroughly considered and optimized every detail in experimental design and communication, ensuring the reliability and precision of the final results.

Miller**

Technical Resources

KMD Bioscience has been deeply involved in antibody research for many years and has established a comprehensive antibody customization platform. This platform spans multiple areas, including the customization of monoclonal antibodies, polyclonal antibodie.　　Technical Articles。

Frequently Asked Questions

Innovative Drug Discovery Platform（FAQs）

How does the platform conduct research on drug mechanisms?

Through cell experiments, animal models, molecular biology techniques, and other methods, we can study how drugs bind to their targets, their mechanisms of action, and drug metabolism, thereby gaining a deeper understanding of the efficacy of drug candidates.
What types of drug discovery can the platform be used for?

The platform supports various types of drug discovery, including small-molecule drugs, antibody drugs, vaccine development, and gene therapy, and can provide flexible technical support tailored to research needs.
How are drug candidates screened?

Using technologies such as high-throughput screening (HTS), virtual screening, and molecular docking, we are able to efficiently screen a large number of chemical molecules and rapidly identify candidate molecules with high affinity and high specificity for the target.
What services does the innovative drug discovery platform offer?

Our innovative drug discovery platform offers a range of services, including target screening, drug candidate screening, optimization of drug candidates, mechanism-of-action studies, toxicity assessment, and preclinical research, covering all stages from early drug discovery to preclinical development.
What is an innovative drug discovery platform?

An innovative drug discovery platform is an integrated technological system designed to help researchers rapidly screen for and discover potential new drugs. It combines a variety of technologies, including genomics, proteomics, chemical library screening, and computational pharmacology, to accelerate the drug discovery process.

Online Ordering

Please fill in the required information below, and we will contact you within 24 hours!

400-621-6806
3599163699
Monday to Friday 9:00-18:00
0